Lichen sclerosus et atrophicus induced by carbamazepine: a case report
Pranteda, G.; Muscianese, M.; Grimaldi, M.; Fidanza, L.; Pranteda, G.; Narcisi, A.; Nistico, S.; Bottoni, U.
International Journal of Immunopathology and Pharmacology 26(3): 791-794
2013
ISSN/ISBN: 0394-6320 PMID: 24067479 Document Number: 667462
We report a case of Lichen Sclerosus in a 73-year-old man who had been treated for epilepsy with carbamazepine. Lichen sclerosus et atrophicus (LSA), also called lichen sclerosus (LS), is a chronic inflammatory cutaneous condition characterized by white plaques with epidermal atrophy and scarring. To date no cases of LSA has been linked to carbamazepine, although in a few cases lichenoid eruptions but without sclero-atrophy have been described after exposure to this drug. Therefore, to our knowledge, this is the first report of a Lichen sclerosus et atrophicus induced by carbamazepine.